Table 1.
Characteristics of patients with testicular germ cell tumors at our Institution
|
Metric
|
|
Number of patients (n = 68)
|
| Demographics | ||
| Mean age at orchiectomy (yr) | 31 (16-53) | |
| Mean BMI at 1st medical oncology visit, n (%) | 29 (18.6-58.4) | |
| Cigarette smoker or ex-smoker | 35 (51) | |
| Current cannabis user, n (%) | 16 (23.5) | |
| Clinicopathologic characteristics | ||
| Histology, n (%) | Seminoma | 19 (28) |
| Non-seminoma | 49 (72) | |
| Pathologic stage, n (%) | IA | 1 (1.5) |
| IB | 1 (1.5) | |
| IS | 6 (9) | |
| IIA | 31 (45.5) | |
| IIB | 10 (14.5) | |
| IIC | 8 (11.5) | |
| III | 1 (1.5) | |
| IIIA | 2 (3) | |
| IIIB | 4 (6) | |
| IIIC | 4 (6) | |
| Laterality, n (%) | Left | 35 (52) |
| Right | 33 (48) | |
| RPLN ≥ 3.0 cm before chemotherapy, n (%) | Yes | 18 (26) |
| No | 50 (74) | |
| Type of chemotherapy | BEP | 58 (85.3%) |
| EP | 4 (5.9%) | |
| BEP + EP | 6 (8.8%) | |
| Cycles of chemotherapy | 1 | 1 (1.5%) |
| 2 | 3 (4.4%) | |
| 3 | 49 (72.0%) | |
| 4 | 13 (19.1%) | |
| 6 | 1 (1.5%) | |
| 7 | 1 (1.5%) | |
| RPLND | Yes | 18 (26.5%) |
| No | 50 (73.5%) | |
| Recurrence after initial chemotherapy | Yes | 5 (7.4%) |
| No | 63 (92.6%) |
BMI: Body mass index; BEP: Bleomycin, etoposide, and cisplatin; EP: Etoposide and cisplatin; RPLN: Retroperitoneal lymph node; RPLND: Retroperitoneal lymph node dissection.